WeVote

Bill

Bill

SD 947

An Act relative to dual diagnosis treatment coverage

194th Legislature (2025-2026) Introduced by Jamie Eldridge and 3 co-sponsors

Massachusetts bill mandates health insurers cover integrated dual diagnosis treatment for concurrent mental health and substance use disorders at parity rates.

0
WeVote Research Nonpartisan
Bill Summary · SD 947

Legislative bill overview

SD 947 requires health insurers in Massachusetts to provide coverage for integrated treatment programs that address both mental health/substance use disorders and co-occurring medical conditions simultaneously. The bill mandates that insurers cover dual diagnosis treatment without imposing different cost-sharing requirements than for single-condition treatment, ensuring parity in access to comprehensive care.

Why is this important

Individuals with concurrent mental health and substance use disorders often face fragmented care systems where these conditions are treated separately, leading to worse outcomes and higher long-term costs. This bill addresses a significant coverage gap that currently forces patients to choose between treating their mental health or addiction, or to navigate multiple insurance claims for integrated services.

Potential points of contention

  • Insurance cost concerns: Insurers may argue that mandating comprehensive dual diagnosis coverage increases premiums and administrative burden, though advocates counter that integrated treatment reduces overall healthcare spending
  • Definition clarity: The bill may need precise definitions of what constitutes "dual diagnosis treatment" and which programs qualify, potentially creating disputes over coverage decisions
  • Provider network limitations: Massachusetts may lack sufficient providers trained in integrated dual diagnosis care, making the mandate difficult to implement initially despite good intentions

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.